Which marker is NOT part of the IHC panel for primary mixed thyroid tumor (second question)?

Prepare for the CMID Test. Study with flashcards and multiple choice questions, each question contains hints and explanations. Get ready for your exam with confidence!

Multiple Choice

Which marker is NOT part of the IHC panel for primary mixed thyroid tumor (second question)?

Explanation:
The main idea here is identifying which immunohistochemical markers are most informative for characterizing a primary mixed thyroid tumor. TTF-1 is a nuclear transcription factor expressed in thyroid tissue, so it helps confirm thyroid origin and supports a follicular/ductal lineage in the tumor. Thyroglobulin is produced by thyroid follicular cells, making it a key marker to establish thyroid differentiation in the tumor’s follicular components. Calcitonin marks medullary thyroid carcinoma because it is produced by the parafollicular C cells, which is crucial when a tumor has a medullary component or mixed features. Galectin-3, while useful as an adjunct marker in thyroid pathology and in some contexts helps differentiate malignant versus benign follicular-pattern lesions, is not a core, definitive indicator of thyroid origin or of specific thyroid lineages. It is not routinely included in the standard panel used to define a primary mixed thyroid tumor.

The main idea here is identifying which immunohistochemical markers are most informative for characterizing a primary mixed thyroid tumor. TTF-1 is a nuclear transcription factor expressed in thyroid tissue, so it helps confirm thyroid origin and supports a follicular/ductal lineage in the tumor. Thyroglobulin is produced by thyroid follicular cells, making it a key marker to establish thyroid differentiation in the tumor’s follicular components. Calcitonin marks medullary thyroid carcinoma because it is produced by the parafollicular C cells, which is crucial when a tumor has a medullary component or mixed features. Galectin-3, while useful as an adjunct marker in thyroid pathology and in some contexts helps differentiate malignant versus benign follicular-pattern lesions, is not a core, definitive indicator of thyroid origin or of specific thyroid lineages. It is not routinely included in the standard panel used to define a primary mixed thyroid tumor.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy